Publication:
Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019

dc.contributor.authorArmocida, Benedetta
dc.contributor.authorMonasta, Lorenzo
dc.contributor.authorSawyer, Susan
dc.contributor.authorBustreo, Flavia
dc.contributor.authorSegafredo, Giulia
dc.contributor.authorCastelpietra, Giulio
dc.contributor.authorRonfani, Luca
dc.contributor.authorPasovic, Maja
dc.contributor.authorHay, Simon
dc.contributor.authorGBD 2019 Europe NCDs in Adolescents Collaborators
dc.contributor.authorPerel, Pablo
dc.contributor.authorBeran, David
dc.contributor.authorPadron-Monedero, Alicia
dc.contributor.funderBill & Melinda Gates Foundation
dc.date.accessioned2023-05-03T08:04:44Z
dc.date.available2023-05-03T08:04:44Z
dc.date.issued2022-06
dc.description.abstractBackground: Disability and mortality burden of non-communicable diseases (NCDs) have risen worldwide; however, the NCD burden among adolescents remains poorly described in the EU. Methods: Estimates were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Causes of NCDs were analysed at three different levels of the GBD 2019 hierarchy, for which mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were extracted. Estimates, with the 95% uncertainty intervals (UI), were retrieved for EU Member States from 1990 to 2019, three age subgroups (10-14 years, 15-19 years, and 20-24 years), and by sex. Spearman's correlation was conducted between DALY rates for NCDs and the Socio-demographic Index (SDI) of each EU Member State. Findings: In 2019, NCDs accounted for 86·4% (95% uncertainty interval 83·5-88·8) of all YLDs and 38·8% (37·4-39·8) of total deaths in adolescents aged 10-24 years. For NCDs in this age group, neoplasms were the leading causes of both mortality (4·01 [95% uncertainty interval 3·62-4·25] per 100 000 population) and YLLs (281·78 [254·25-298·92] per 100 000 population), whereas mental disorders were the leading cause for YLDs (2039·36 [1432·56-2773·47] per 100 000 population) and DALYs (2040·59 [1433·96-2774·62] per 100 000 population) in all EU Member States, and in all studied age groups. In 2019, among adolescents aged 10-24 years, males had a higher mortality rate per 100 000 population due to NCDs than females (11·66 [11·04-12·28] vs 7·89 [7·53-8·23]), whereas females presented a higher DALY rate per 100 000 population due to NCDs (8003·25 [5812·78-10 701·59] vs 6083·91 [4576·63-7857·92]). From 1990 to 2019, mortality rate due to NCDs in adolescents aged 10-24 years substantially decreased (-40·41% [-43·00 to -37·61), and also the YLL rate considerably decreased (-40·56% [-43·16 to -37·74]), except for mental disorders (which increased by 32·18% [1·67 to 66·49]), whereas the YLD rate increased slightly (1·44% [0·09 to 2·79]). Positive correlations were observed between DALY rates and SDIs for substance use disorders (rs=0·58, p=0·0012) and skin and subcutaneous diseases (rs=0·45, p=0·017), whereas negative correlations were found between DALY rates and SDIs for cardiovascular diseases (rs=-0·46, p=0·015), neoplasms (rs=-0·57, p=0·0015), and sense organ diseases (rs=-0·61, p=0·0005). Interpretation: NCD-related mortality has substantially declined among adolescents in the EU between 1990 and 2019, but the rising trend of YLL attributed to mental disorders and their YLD burden are concerning. Differences by sex, age group, and across EU Member States highlight the importance of preventive interventions and scaling up adolescent-responsive health-care systems, which should prioritise specific needs by sex, age, and location.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study was funded by the Bill & Melinda Gates Foundation.es_ES
dc.format.number6es_ES
dc.format.page367-383es_ES
dc.format.volume6es_ES
dc.identifier.citationLancet Child Adolesc Health. 2022 Jun;6(6):367-383.es_ES
dc.identifier.doi10.1016/S2352-4642(22)00073-6es_ES
dc.identifier.e-issn2352-4650es_ES
dc.identifier.journalThe Lancet. Child & adolescent healthes_ES
dc.identifier.pubmedID35339209es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15936
dc.language.isoenges_ES
dc.publisherElsevier
dc.relation.publisherversionhttps://doi.org/10.1016/S2352-4642(22)00073-6es_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidad (ENS)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshDisabled Personses_ES
dc.subject.meshNoncommunicable Diseaseses_ES
dc.subject.meshAdolescentes_ES
dc.subject.meshFemalees_ES
dc.subject.meshGlobal Burden of Diseasees_ES
dc.subject.meshHumanses_ES
dc.subject.meshLife Expectancyes_ES
dc.subject.meshMalees_ES
dc.subject.meshRisk Factorses_ES
dc.titleBurden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationfc113e6e-26ec-43c3-91ed-81a88ded836e
relation.isAuthorOfPublication.latestForDiscoveryfc113e6e-26ec-43c3-91ed-81a88ded836e
relation.isFunderOfPublication7f469bdd-6b2f-4fa0-8d02-d769f14a04f5
relation.isFunderOfPublication.latestForDiscovery7f469bdd-6b2f-4fa0-8d02-d769f14a04f5
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BurdenNon-communicableDiseases_2022.pdf
Size:
717.75 KB
Format:
Adobe Portable Document Format
Description: